IGC Pharma (IGC) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.25, -1.60% vs the prior close of $0.25.
- Volume 403.97K shares, 0.5x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
IGC dips 1.6% to $0.25, a 1-month low, 9 down days in a row. Closed at $0.25, -1.60% vs the prior close of $0.25. Day range $0.24–$0.26, opened at $0.26.
IGC daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — IGC dips 1.6% to $0.25, a 1-month low, 9 down days in a row
- Closed at $0.25, -1.60% vs the prior close of $0.25. Day range $0.24–$0.26, opened at $0.26.
- Volume was 403.97K shares, 0.5x its 50-day average of 834.05K — lighter than usual.
- Price is -13.0% vs its 50-day average ($0.28) and -13.1% vs its 200-day average ($0.28).
- 52-week range $0.24–$0.45; today's close sits at 3% of that range, 45.3% below the 52-week high.
- That makes 9 straight losses.
Oct 15, 2026 — IGC ends flat (+0.0%) to $0.25, 8 down days in a row
- Closed at $0.25, +0.00% vs the prior close of $0.25. Day range $0.25–$0.26, opened at $0.26.
- Volume was 781.40K shares, 0.9x its 50-day average of 822.58K.
- Price is -11.6% vs its 50-day average ($0.28) and -11.7% vs its 200-day average ($0.28).
- 52-week range $0.24–$0.45; today's close sits at 5% of that range, 44.4% below the 52-week high.
- That makes 8 straight losses.
Oct 14, 2026 — IGC slides 7.4% to $0.25, a 1-month low, 7 down days in a row
- Closed at $0.25, -7.41% vs the prior close of $0.27. Day range $0.25–$0.26, opened at $0.26.
- Volume was 946.10K shares, 1.2x its 50-day average of 809.82K.
- Price is -11.6% vs its 50-day average ($0.28) and -11.8% vs its 200-day average ($0.28).
- 52-week range $0.24–$0.45; today's close sits at 5% of that range, 44.4% below the 52-week high.
- That makes 7 straight losses.
Oct 13, 2026 — IGC slides 3.6% to $0.27, 6 down days in a row
- Closed at $0.27, -3.57% vs the prior close of $0.28. Day range $0.26–$0.27, opened at $0.27.
- Volume was 422.10K shares, 0.5x its 50-day average of 808.90K — lighter than usual.
- Price is -4.5% vs its 50-day average ($0.28) and -4.8% vs its 200-day average ($0.28).
- 52-week range $0.24–$0.45; today's close sits at 14% of that range, 40.0% below the 52-week high.
- That makes 6 straight losses.
Oct 12, 2026 — IGC ends flat (+0.0%) to $0.28, 5 down days in a row
- Closed at $0.28, +0.00% vs the prior close of $0.28. Day range $0.27–$0.29, opened at $0.28.
- Volume was 573.00K shares, 0.7x its 50-day average of 801.13K.
- Price is -0.8% vs its 50-day average ($0.28) and -1.4% vs its 200-day average ($0.28).
- 52-week range $0.24–$0.45; today's close sits at 19% of that range, 37.8% below the 52-week high.
- That makes 5 straight losses.
Oct 9, 2026 — IGC ends flat (+0.0%) to $0.28, 4 down days in a row
- Closed at $0.28, +0.00% vs the prior close of $0.28. Day range $0.28–$0.28, opened at $0.28.
- Volume was 232.20K shares, 0.3x its 50-day average of 801.59K — lighter than usual.
- Price is -0.6% vs its 50-day average ($0.28) and -1.4% vs its 200-day average ($0.28).
- 52-week range $0.24–$0.45; today's close sits at 19% of that range, 37.8% below the 52-week high.
- That makes 4 straight losses.
Oct 8, 2026 — IGC ends flat (+0.0%) to $0.28, 3 down days in a row
- Closed at $0.28, +0.00% vs the prior close of $0.28. Day range $0.28–$0.29, opened at $0.28.
- Volume was 626.40K shares, 0.8x its 50-day average of 809.96K.
- Price is -0.4% vs its 50-day average ($0.28) and -1.4% vs its 200-day average ($0.28).
- 52-week range $0.24–$0.45; today's close sits at 19% of that range, 37.8% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — IGC ends flat (+0.0%) to $0.28
- Closed at $0.28, +0.00% vs the prior close of $0.28. Day range $0.28–$0.29, opened at $0.29.
- Volume was 306.80K shares, 0.4x its 50-day average of 810.68K — lighter than usual.
- Price is -0.1% vs its 50-day average ($0.28) and -1.5% vs its 200-day average ($0.28).
- 52-week range $0.24–$0.45; today's close sits at 19% of that range, 37.8% below the 52-week high.
Oct 6, 2026 — IGC ends flat (+0.0%) to $0.28
- Closed at $0.28, +0.00% vs the prior close of $0.28. Day range $0.28–$0.29, opened at $0.28.
- Volume was 1.11M shares, 1.4x its 50-day average of 790.62K.
- Price is -0.0% vs its 50-day average ($0.28) and -1.6% vs its 200-day average ($0.28).
- 52-week range $0.24–$0.45; today's close sits at 19% of that range, 37.8% below the 52-week high.
Oct 5, 2026 — IGC jumps 3.7% to $0.28 on 2.3x normal volume
- Closed at $0.28, +3.70% vs the prior close of $0.27. Day range $0.27–$0.29, opened at $0.28.
- Volume was 1.77M shares, 2.3x its 50-day average of 759.30K — unusually heavy trading.
- Price is +0.1% vs its 50-day average ($0.28) and -1.7% vs its 200-day average ($0.28).
- 52-week range $0.24–$0.45; today's close sits at 19% of that range, 37.8% below the 52-week high.
Oct 2, 2026 — IGC ends flat (+0.0%) to $0.27, 7 down days in a row
- Closed at $0.27, +0.00% vs the prior close of $0.27. Day range $0.27–$0.28, opened at $0.28.
- Volume was 630.60K shares, 0.8x its 50-day average of 749.20K.
- Price is -3.3% vs its 50-day average ($0.28) and -5.3% vs its 200-day average ($0.29).
- 52-week range $0.24–$0.45; today's close sits at 14% of that range, 40.0% below the 52-week high.
- That makes 7 straight losses.
IGC latest news & SEC filings
Every SEC filing by or about IGC in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Mukunda Ram gifted 100,000 shares on Sep 25, 2026; now holds 6,775,563
- Mukunda Ram gifted 100,000 shares on Sep 25, 2026; now holds 6,675,563
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Grimaldi Claudia gifted 150,000 shares on Sep 25, 2026; now holds 3,271,092
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $265.00K (prior year $328.00K) (-19.2% vs Jun 30, 2025)
- Net income: -$2.94M (prior year -$1.60M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.03 (prior year -$0.02) (loss widened vs Jun 30, 2025)
Jul 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Jul 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 3.02 — Sold unregistered shares.
Jul 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade IGC
- Last results release: Jul 15, 2011 (8-K Item 2.02). Previous ones: Feb 23, 2011, Jul 21, 2008, Aug 18, 2006. Based on that rhythm, the next report is likely around Oct 14, 2011 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.87% (largest 7.4%).
- Liquidity: about 667.97K shares (≈$164.32K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.25 vs a range of $0.24–$0.45 (3% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 10-Q Aug 14, 2026; 8-K Jul 14, 2026; 8-K Jul 6, 2026.
- Share count: 103.38M shares outstanding (Aug 5, 2026), +13.8% vs a year earlier — notable dilution.
- Listing: NYSE · industry: Pharmaceutical Preparations.
IGC market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.26 | 0.26 | 0.24 | 0.25 | 403.97K |
| Oct 15, 2026 | 0.26 | 0.26 | 0.25 | 0.25 | 781.40K |
| Oct 14, 2026 | 0.26 | 0.26 | 0.25 | 0.25 | 946.10K |
| Oct 13, 2026 | 0.27 | 0.27 | 0.26 | 0.27 | 422.10K |
| Oct 12, 2026 | 0.28 | 0.29 | 0.27 | 0.28 | 573.00K |
| Oct 9, 2026 | 0.28 | 0.28 | 0.28 | 0.28 | 232.20K |
| Oct 8, 2026 | 0.28 | 0.29 | 0.28 | 0.28 | 626.40K |
| Oct 7, 2026 | 0.29 | 0.29 | 0.28 | 0.28 | 306.80K |
| Oct 6, 2026 | 0.28 | 0.29 | 0.28 | 0.28 | 1.11M |
| Oct 5, 2026 | 0.28 | 0.29 | 0.27 | 0.28 | 1.77M |
| Oct 2, 2026 | 0.28 | 0.28 | 0.27 | 0.27 | 630.60K |
| Oct 1, 2026 | 0.27 | 0.28 | 0.27 | 0.27 | 449.90K |
| Sep 30, 2026 | 0.27 | 0.28 | 0.27 | 0.27 | 808.90K |
| Sep 29, 2026 | 0.28 | 0.28 | 0.27 | 0.27 | 523.70K |
| Sep 28, 2026 | 0.29 | 0.30 | 0.27 | 0.27 | 1.10M |
| Sep 25, 2026 | 0.28 | 0.29 | 0.28 | 0.28 | 681.60K |
| Sep 24, 2026 | 0.28 | 0.29 | 0.28 | 0.28 | 332.80K |
| Sep 23, 2026 | 0.29 | 0.29 | 0.28 | 0.29 | 540.50K |
| Sep 22, 2026 | 0.27 | 0.28 | 0.27 | 0.28 | 609.70K |
| Sep 21, 2026 | 0.29 | 0.29 | 0.27 | 0.27 | 507.10K |
About IGC Pharma
IGC Pharma (IGC) is listed on the NYSE and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in POTOMAC, MD. State of incorporation: MD. Fiscal year ends December 31. SEC CIK 1326205.
IGC board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Claudia Grimaldi | PFO | Sep 29, 2026 |
| Terry L Lierman | Director | Oct 21, 2025 |
| James P Moran | Director | Apr 6, 2026 |
| Ram Mukunda | CEO | Sep 29, 2026 |
| Richard K Prins | Director | Apr 6, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Claudia Grimaldi | PFO | Sep 29, 2026 |
| Ram Mukunda | CEO | Sep 29, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
IGC financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Mar 31, 2025 | $1.27M | $-7.12M | -0.09 | $-4.79M |
| Mar 31, 2024 | $1.34M | $-13.00M | -0.22 | $-5.20M |
| Mar 31, 2023 | $911.00K | $-11.51M | — | $-7.05M |
| Mar 31, 2022 | $397.00K | $-15.02M | — | $-7.46M |
| Mar 31, 2021 | $898.00K | $-8.81M | — | $-10.80M |
Latest balance sheet: total assets $9.50M, total liabilities $3.36M, cash $331.00K (as of Jun 30, 2026).
IGC earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 15, 2011 | 8-K Item 2.02 (results) | — |
| Feb 23, 2011 | 8-K Item 2.02 (results) | — |
| Jul 21, 2008 | 8-K Item 2.02 (results) | — |
| Aug 18, 2006 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on IGC
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.